Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: Recent insights and remaining challenges

Learning and Memory

Volumn 8, Issue 3, 2001, Pages 121-133

  Brinton, R D ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ESTROGEN; ESTROGEN RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBTYPE; REGULATOR PROTEIN;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; DEGENERATIVE DISEASE; ESTROGEN ACTIVITY; ESTROGEN THERAPY; MEMORY; MENOPAUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEUROTROPISM; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ALZHEIMER DISEASE; ANIMALS; ESTROGENS; HUMANS; MEMORY; NEURONAL PLASTICITY; NEUROPROTECTIVE AGENTS; RECEPTORS, ESTROGEN;

EID: 0034968269     PISSN: 10720502     EISSN: None     Source Type: Journal    
DOI: 10.1101/lm.39601     Document Type: Review

References (99)

1. Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription
2. The female sex hormone oestrogen as neuroprotectant: Activities at various levels
3. Neuroprotection against oxidative stress by estrogens: Structure-activity relationship
4. The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus
5. The role of estrogen in the treatment of Alzheimer's disease
6. Estrogens and Alzheimer's disease
7. 17β-estradiol induction of filopodial growth in cultured hippocampal neurons within minutes of exposure
8. The Women's Health Initiative estrogen replacement therapy is neurotrophic and neuroprotective
9. Comparative analysis of estrogen replacement therapy and the SERM raloxifene on markers of neural plasticity and neuroprotection
10. Effets neuroprotecteurs des composé estrogéiques des ece
11. Sex hormones and their brain receptors
12. Equilin, a principal component of the estrogen replacement therapy premarin, increases the growth of cortical neurons via an NMDA receptor-dependent mechanism
13. 17β-estradiol increases the growth and survival of cultured cortical neurons
14. Therapeutic advances and challenges in the treatment of Alzheimer's disease
15. Molecular basis of agonism and antagonism in the oestrogen receptor
16. Effect of select phytoestrogens on β-amyloid peptide and hydrogen peroxide induced neurotoxicity in cultured rat hippocampal neurons
17. Mechanisms of conjugated equine estrogen regulation of intracellular calcium in cultured rat hippocampal neurons
18. Identification of a splice variant of the rat estrogen receptor beta gene
19. Variations of synaptotagmin I, synaptotagmin IV, and synaptophysin mRNA levels in rat hippocampus during the estrous cycle
20. Molecular chaperones and subcellular trafficking of steroid receptors
21. Rac1 GTPases control filopodia formation, cell motility, endocytosis, cytokinesis and development in Dictyostelium
22. Evolutions: Alzheimer's disease
23. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type
24. 17β-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation
25. Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus
26. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons
27. Learning enhances adult neurogenesis in the hippocampal formation
28. Phenolic A ring requirement for the neuroprotective effects of steroids
29. Nuclear estrogen receptor-independent neuroprotection by estratrienes: A novel interaction with glutathione
30. The nonfeminizing enantiomer of 17ss-estradiol exerts protective effects in neuronal cultures and a rat model of cerebral ischemia. Synthesis and biological evaluation of 17beta-alkoxyestra-1,3,5(10)-trienes as potential neuroprotectants against oxidative stress
31. Neuroprotective effects of phenolic A ring oestrogens
32. Synthesis and pharmacology of conformationally restricted raloxifene analogues: Highly potent selective estrogen receptor modulators
33. Therapeutic potential of selective estrogen receptor modulators
34. Women's concerns with hormone replacement therapy-compliance issues
35. Structure, development, and plasticity of dendritic spines
36. Estrogen for Alzheimer's disease in women: Randomized, double-blind, placebo-controlled trial
37. New populations of old add to poor nations' burdens
38. Estrogen receptor variants
39. Estrogen receptors: Bioactivities and interactions with cell signaling pathways
40. Estrogen receptors: Selective ligands, partners, and distinctive pharmacology
41. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
42. The estrogen receptor beta subtype: A novel mediator of estrogen action in neuroendocrine systems
43. Oestrogen receptor function at classical and alternative response elements
44. Estrogen enhances uptake of amyloid beta-protein by microglia derived from the human cortex
45. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats
46. A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regular of estrogen action
47. Estrogen actions in the central nervous system
48. Nuclear receptor coregulators: Cellular and molecular biology
49. Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites
50. Granule cells in aging rats are sexually dimorphic in their response to estradiol
51. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial
52. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons
53. Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones
54. Morphological plasticity of dendritic spines in central neurons is mediated by activation of cAMP response element binding protein
55. Menopausal symptoms in women of various ages
56. Progestins can antagonize estradiol induced neuroprotection without antagonizing MAP kinase activation
57. Effect of the SERM tamoxifene on neuronal outgrowth and survival
58. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding
59. Ovariectomy and 17β-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain
60. Effects of estrogen on memory function in surgically menopausal women
61. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: Relevance to Alzheimer's disease
62. Estradiol increases spine density and NMDA-dependent CA2+ transients in spines of CA1 pyramidal neurons from hippocampal slices, CREB activation mediates plasticity in cultured hippocampal neurons
63. Differential expression of estrogen receptor beta splice variants in rat brain: Identification and characterization of a novel variant missing exon 4
64. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein
65. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells
66. Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect?
67. Estradiol regulates GABAergic input to hippocampal CA1 pyramidal cells in the adult female rat
68. Memory retention is modulated by acute estradiol and progesterone replacement
69. Caveolin-1 potentiates estrogen receptor alpha (ERalpha) signaling. Caveolin-1 drives ligand-independent nuclear translocation and activation of ERalpha
70. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women
71. Impact of changing hormonal mileu on psychological functioning
72. Oestrogen and cognitive function throughout the female lifespan
73. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
74. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system
75. The Women's Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progress of dementia
76. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons
77. Estradiol and progesterone elicit AKT and ERK phosphorylation in explants of the cerebral cortex
78. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: Convergence of estrogen and neurotrophin signaling pathways
79. Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat
80. On the genesis of sexual differentiation of the general nervous system: Morphogenetic consequences of steroidal exposure and possible role of alpha-fetoprotein
81. Novel sites and mechanisms of oestrogen action in the brain
82. Membrane-initiated activation of MAPK by estrogen in stably transfected rat-2-fibroblasts
83. The estrogen receptor family
84. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions
85. Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB
86. Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus
87. Alzheimer's disease: An international public health problem-clinical goals, strategies, and outcomes
88. Steroid hormone receptors: Evolution, ligands, and molecular basis of biologic function
89. Estradiol modulates anti-apoptotic signals in cortical explant cultures
90. Estradiol protects against ischemic brain injury in middle-aged rats
91. Patch-clamp analysis of direct steroidal modulation of glutamate receptor-channels
92. Electrophysiological and cellular effects of estrogen on neuronal function
93. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism
94. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: Correlation with dendritic spine density
95. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia
96. NMDA channel regulation by channel-associated protein tyrosine kinase Src